HC Wainwright restated their buy rating on shares of Eledon Pharmaceuticals (NASDAQ:ELDN – Free Report) in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a $13.00 price objective on the stock. Eledon Pharmaceuticals Stock Performance Shares of NASDAQ ELDN opened at $2.07 on Friday. The firm’s 50-day simple moving average […]
Related Keywords
Canada , , News Ratings For Eledon Pharmaceuticals Daily , Eledon Pharmaceuticals Stock Performance , Institutional Investors Weigh In On Eledon Pharmaceuticals , Eledon Pharmaceuticals , Eledon Pharmaceuticals Inc , Royal Bank , Eledon Pharmaceuticals Company Profile , Vanguard Group Inc , Armistice Capital , Renaissance Technologies , Free Report , Get Free Report , Eledon Pharmaceuticals Daily , Nasdaq Eldn , Heldn , Medical , Reiterated Rating , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.